AP NEWS

Opportunities in the Global Psoriasis Therapeutics Market to 2026 - Player Profiles for J&J, Novartis, Merck, Janssen, Eli Lilly and Co, Eisai, Celgene, BMS, and more - ResearchAndMarkets.com

August 30, 2018

DUBLIN--(BUSINESS WIRE)--Aug 30, 2018--The “Psoriasis Therapeutics - Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering.

According to the report, the Global Psoriasis Therapeutics market is expected to grow at a CAGR of 10.5% during the forecast period.

Availability of new diagnostic procedures, growing preference for combination therapies, increasing awareness about treatment, rising demand for improved healthcare infrastructure and changing lifestyle of people are some factors influencing the market growth.

Further, better diagnostic tools availablity for psoriasis will result in increasing the treatmento seeking patient population which in turn boost the market’s growth prospects in the coming years.

Depending on molecule, the biologics segment dominated the market. The growth of this segment is also attributed the launch of novel biologics like Cosentyx by Novartis.

By geography, North America dominated the global market due to the established healthcare infrastructure, high adoption of therapeutics and presence of key manufacturers in the U.S. Moreover, increasing prevalence and favorable government initiatives are some drivers fueling the market growth.

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porter’s Five Forces Analysis

5 Global Psoriasis Therapeutics Market, By Dosage Form

6 Global Psoriasis Therapeutics Market, By Molecule

7 Global Psoriasis Therapeutics Market, By Mechanism of Action

8 Global Psoriasis Therapeutics Market, By Route of Administration

9 Global Psoriasis Therapeutics Market, By Distribution Channel

10 Global Psoriasis Therapeutics Market, By Geography

11 Key Developments

12 Company Profiling

Johnson & Johnson Novartis AG Merck & Co. Inc. Janssen Biotech Inc. Incyte Corp. Eli Lilly and Company Eisai Co. Ltd. Celgene Corporation Bristol Myers Squibb Co. AstraZeneca Amgen Inc. AbbVie Inc. LEO Pharma A/S UCB S.A. Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/research/9gwqbj/opportunities_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005378/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Psoriasis Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL RETAIL COSMETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/30/2018 07:03 AM/DISC: 08/30/2018 07:04 AM

http://www.businesswire.com/news/home/20180830005378/en

AP RADIO
Update hourly